Agios shapes up to be among the strongest biotechs to go public last year
October 16, 2014 at 14:13 PM EDT
With a recent full-length feature article in The New Yorker magazine and the enthusiastic support of Jim Cramer of CNBC, Cambridge-based Agios Pharmaceuticals is shaping up to be one of the most successful biotechs of the local IPO class of 2013...
